Guro Kristin Melve | University of Bergen

Guro Kristin

Melve

STILLING UTENFOR REG

Visit Address:

Haukeland universitetssykehus, Laboratoriebygget

5021 Bergen

Postal Address:

Postboks 7804

5021 Bergen

Phone:

+47 55 97 24 72

E-mail:

Journal articles

Bruserud, Øystein; Liseth, Knut; Stamnesfet, Siren; Cacic, Daniel Limi; Melve, Guro Kristin; Kristoffersen, Einar Klæboe; Hervig, Tor; Reikvam, Håkon. 2013. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfusion Medicine. 23: 397-406. doi: 10.1111/tme.12067
Mosevoll, Knut Anders; Akkøk, Cigdem Ahaein; Hervig, Tor; Melve, Guro Kristin; Bruserud, Øystein; Reikvam, Håkon. 2013. Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 15: 850-860. doi: 10.1016/j.jcyt.2013.02.008
Reikvam, Håkon; Kittang, Astrid Marta Olsnes; Melve, Guro Kristin; Mosevoll, Knut Anders; Bentsen, Pål Tore; Ersvær, Elisabeth; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2013. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions? Current Cancer Drug Targets. 13: 30-47. doi: 10.2174/1568009611309010030

Reikvam, Håkon; Mosevoll, Knut Anders; Melve, Guro Kristin; Günther, Clara-Cecilie; Sjo, Malvin; Bentsen, Pål Tore; Bruserud, Øystein. 2012. The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of posttransplantation complications. Biology of blood and marrow transplantation. 18: 190-199. doi: 10.1016/j.bbmt.2011.10.007

Akkæk, Cigdem Ahaein; Hervig, Tor; Stamnesfet, Siren; Nesthus, Ingerid; Melve, Guro Kristin; Lassalle, Philippe; Bruserud, Øystein. 2011. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 13: 1259-1268. doi: 10.3109/14653249.2011.605117
Akkæk, Cigdem Ahaein; Liseth, Knut; Melve, Guro Kristin; Ersvær, Elisabeth; Hervig, Tor; Bruserud, Øystein. 2011. Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts? Cytotherapy. 13: 1013-1024. doi: 10.3109/14653249.2011.574117
Ersvær, Elisabeth; Melve, Guro Kristin; Bruserud, Øystein. 2011. Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation? Cancer Immunology and Immunotherapy. 60: 1669-1681. doi: 10.1007/s00262-011-1118-z
Melve, Guro Kristin; Ersvær, Elisabeth; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2011. The chemokine system. in allogeneic stem-cell transplantation: a possible therapeutic target? Expert Review of Hematology. 4: 563-576. doi: 10.1586/EHM.11.54

Melve, Guro Kristin; Hervig, Tor; Seghatchian, Jerard. 2010. Self-treatment of an ABO-incompatible blood transfusion. Transfusion and apheresis science. 42: 215-216. doi: 10.1016/j.transci.2010.01.019
Reikvam, Håkon; Melve, Guro Kristin; Svendheim, Kjersti; Hervig, Tor. 2010. Why is potentional blood donors deferred from donation? Haematologica. 95: 738-738.

Melve, Guro Kristin; Myrmel, Helge; Eide, Geir Egil; Hervig, Tor. 2009. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors. Transfusion. 49: 2359-2365. doi: 10.1111/j.1537-2995.2009.02320.x
Melve, Guro Kristin; Myrmel, Helge; Eide, Geir Egil; Hervig, Tor. 2009. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors. Transfusion. 49: 2359-2365. doi: 10.1111/j.1537-2995.2009.02320.x